News
Shares of IQVIA Holdings Inc. IQV slipped 2.97% to $185.86 Thursday, on what proved to be an all-around rough trading session ...
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article ...
Growth in the Patient Data Hub Solutions Market is driven by healthcare interoperability and IT advancements. Key insights include market segmentation, growth drivers, and Microsoft's AI innovations ...
The company’s FDA-approved first generic sertraline capsules secured a 180‑day exclusivity period, highlighting strategic generic development pathways.
In this episode presented by IQVIA, BioSpace’s head of insights Lori Ellis discusses the concerns and opportunities of ...
The Scotsman Life Science Conference 2025 will bring together industry leaders, innovators and researchers to discuss the ...
Indian drugmaker Mankind Pharma reported a lower first-quarter profit on Thursday, as mounting expenses outpaced strong ...
Michael Salfino takes a closer look at Tyreek Hill to determine if his 2024 slide was anomalous or a sign of age-based ...
Traditional design & build approaches often face challenges due to fragmented processes and limited visibility ...
See the latest IQVIA Holdings Inc stock price (IQV:XNYS), related news, valuation, dividends and more to help you make your investing decisions.
Eli Lilly said on Thursday that its newer diabetes drug Mounjaro outperformed Trulicity, its previously top-selling ...
Liraglutide injection single-patient-use prefilled pens and glucagon for injection vials will be manufactured at Lupin’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results